<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">23800048</PMID>
        <DateCompleted>
            <Year>2013</Year>
            <Month>11</Month>
            <Day>01</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2018</Year>
            <Month>11</Month>
            <Day>13</Day>
        </DateRevised>
        <Article PubModel="Electronic">
            <Journal>
                <ISSN IssnType="Electronic">2047-783X</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>18</Volume>
                    <PubDate>
                        <Year>2013</Year>
                        <Month>Jun</Month>
                        <Day>24</Day>
                    </PubDate>
                </JournalIssue>
                <Title>European journal of medical research</Title>
                <ISOAbbreviation>Eur. J. Med. Res.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>High serum HTATIP2/TIP30 level in serous ovarian cancer as prognostic or diagnostic marker.</ArticleTitle>
            <Pagination>
                <MedlinePgn>18</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1186/2047-783X-18-18</ELocationID>
            <Abstract>
                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Human HIV-1 TAT interactive protein 2 (HTATIP2/TIP30) is an evolutionarily conserved gene that is expressed ubiquitously in human tissues and some tumor tissues. This protein has been found to be associated with some gynecological cancers; as such, this study aimed to investigate blood HTATIP2/TIP30 levels in patients with ovarian cancer.</AbstractText>
                <AbstractText Label="METHODS" NlmCategory="METHODS">Twenty-three women with ovarian cancer and 18 patients with various non-cancerous gynecological complaints (for example, dysfunctional uterine bleeding, fibroids, and urinary incontinence) were included in the study. The pathological diagnosis of ovarian cancer was adenocarcinoma. HTATIP2/TIP30 concentration in the patients' blood samples was determined using ELISA kits.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">The HTATIP2/TIP30 level was significantly higher in the cancer group than in the control group (1.84 ± 0.82 versus 0.57 ± 0.13 ng/ml, mean ± SD).</AbstractText>
                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">We demonstrated the potential role of HTATIP2/TIP30 in ovarian cancer for the first time, thereby enlightening future studies targeting HTATIP2/TIP30 in ovarian cancer treatment, diagnosis, and prevention.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Kumtepe</LastName>
                    <ForeName>Yakup</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Obstetrics and Gynecology, Ataturk University, Faculty of Medicine, Erzurum 25240, Turkey.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Halici</LastName>
                    <ForeName>Zekai</ForeName>
                    <Initials>Z</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sengul</LastName>
                    <ForeName>Ozlem</ForeName>
                    <Initials>O</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kunak</LastName>
                    <ForeName>Celalettin Semih</ForeName>
                    <Initials>CS</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bayir</LastName>
                    <ForeName>Yasin</ForeName>
                    <Initials>Y</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kilic</LastName>
                    <ForeName>Nergiz</ForeName>
                    <Initials>N</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Cadirci</LastName>
                    <ForeName>Elif</ForeName>
                    <Initials>E</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pulur</LastName>
                    <ForeName>Alparslan</ForeName>
                    <Initials>A</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bayraktutan</LastName>
                    <ForeName>Zafer</ForeName>
                    <Initials>Z</Initials>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2013</Year>
                <Month>06</Month>
                <Day>24</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Eur J Med Res</MedlineTA>
            <NlmUniqueID>9517857</NlmUniqueID>
            <ISSNLinking>0949-2321</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D014157">Transcription Factors</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>EC 2.3.1.-</RegistryNumber>
                <NameOfSubstance UI="D000123">Acetyltransferases</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>EC 2.3.1.48</RegistryNumber>
                <NameOfSubstance UI="C111246">HTATIP2 protein, human</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000123" MajorTopicYN="N">Acetyltransferases</DescriptorName>
                <QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000230" MajorTopicYN="N">Adenocarcinoma</DescriptorName>
                <QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName>
                <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
                <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D003937" MajorTopicYN="N">Diagnosis, Differential</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005831" MajorTopicYN="N">Genital Diseases, Female</DescriptorName>
                <QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName>
                <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
                <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D015658" MajorTopicYN="N">HIV Infections</DescriptorName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
                <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
                <QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D015497" MajorTopicYN="N">HIV-1</DescriptorName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
                <QualifierName UI="Q000472" MajorTopicYN="N">pathogenicity</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D058990" MajorTopicYN="N">Molecular Targeted Therapy</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D010051" MajorTopicYN="N">Ovarian Neoplasms</DescriptorName>
                <QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName>
                <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
                <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D014157" MajorTopicYN="N">Transcription Factors</DescriptorName>
                <QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName>
            </MeshHeading>
        </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2012</Year>
                <Month>10</Month>
                <Day>23</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2013</Year>
                <Month>05</Month>
                <Day>31</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2013</Year>
                <Month>6</Month>
                <Day>27</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2013</Year>
                <Month>6</Month>
                <Day>27</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2013</Year>
                <Month>11</Month>
                <Day>2</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">23800048</ArticleId>
            <ArticleId IdType="pii">2047-783X-18-18</ArticleId>
            <ArticleId IdType="doi">10.1186/2047-783X-18-18</ArticleId>
            <ArticleId IdType="pmc">PMC3695774</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>J Oncol. 2010;2010:568938</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20037743</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Adv Exp Med Biol. 2000;480:93-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10959414</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Physiol Rev. 2001 Oct;81(4):1535-65</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11581496</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 1998 Mar 3;95(5):2146-51</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9482853</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Histopathology. 2001 Feb;38(2):87-95</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11207821</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cochrane Database Syst Rev. 2011;(10):CD007927</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21975775</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Semin Oncol. 2001 Oct;28(5 Suppl 16):4-11</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11706390</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell. 1983 Oct;34(3):779-87</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">6414718</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mol Cell Biol. 2000 Jan;20(2):583-93</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10611237</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Oncogene. 2001 Jan 11;20(2):270-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11313954</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Oncol. 2003 Jan 15;21(2):283-90</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12525520</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Exp Hematol. 1999 Oct;27(10):1533-41</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10517495</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>World J Gastroenterol. 2005 Jan 14;11(2):221-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15633220</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Protein Expr Purif. 2008 Jan;57(1):63-71</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17950618</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Res. 2001 May 15;61(10):3858-62</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11358796</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Oncogene. 1997 May 8;14(18):2167-73</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9174052</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Endocr Relat Cancer. 2000 Sep;7(3):143-64</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11021963</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Oncogene. 2000 Feb 21;19(8):968-88</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10713680</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Oncogene. 1992 Aug;7(8):1587-94</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">1630819</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Cancer Res Clin Oncol. 2005 Sep;131(9):603-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15931508</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Recent Pat Anticancer Drug Discov. 2010 Nov;5(3):251-60</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20524931</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>EMBO J. 2000 Mar 1;19(5):956-63</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10698937</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hepatology. 2006 Jul;44(1):205-15</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16799960</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Res. 2003 Dec 15;63(24):8763-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14695192</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell. 1986 May 23;45(4):485-95</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">3011271</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Br J Obstet Gynaecol. 1989 Aug;96(8):889-92</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">2775686</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Biol Chem. 2004 Jun 25;279(26):27781-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15073177</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mol Cancer. 2011;10:125</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21962244</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Pathol. 2009 May;174(5):1931-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19349353</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Acta Medica (Hradec Kralove). 2006;49(3):161-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17117604</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>

</PubmedArticleSet>